Serdal Uğurlu

3.7k total citations
191 papers, 2.2k citations indexed

About

Serdal Uğurlu is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Serdal Uğurlu has authored 191 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 67 papers in Rheumatology and 47 papers in Immunology. Recurrent topics in Serdal Uğurlu's work include Inflammasome and immune disorders (64 papers), Ocular Diseases and Behçet’s Syndrome (39 papers) and Systemic Lupus Erythematosus Research (27 papers). Serdal Uğurlu is often cited by papers focused on Inflammasome and immune disorders (64 papers), Ocular Diseases and Behçet’s Syndrome (39 papers) and Systemic Lupus Erythematosus Research (27 papers). Serdal Uğurlu collaborates with scholars based in Türkiye, United States and Germany. Serdal Uğurlu's co-authors include Huri Özdoğan, Emire Seyahi, Hasan Yazıcı, Vedat Hamuryudan, Melike Melikoğlu, Erkan Çağlar, Necdet Süt, Koray Taşçılar, Sebahattin Yurdakul and Gülen Hatemi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

Serdal Uğurlu

156 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serdal Uğurlu Türkiye 24 704 700 629 523 498 191 2.2k
José Luís Callejas-Rubio Spain 27 206 0.3× 426 0.6× 170 0.3× 1.0k 1.9× 722 1.4× 143 2.2k
Gideon Nesher Israel 30 214 0.3× 1.3k 1.9× 169 0.3× 1.4k 2.8× 388 0.8× 107 2.8k
Francesco Caso Italy 35 839 1.2× 279 0.4× 390 0.6× 2.0k 3.9× 1.9k 3.8× 137 3.9k
Luisa Costa Italy 33 558 0.8× 182 0.3× 286 0.5× 2.1k 4.0× 1.9k 3.7× 130 3.4k
Mehmet Soy Türkiye 19 248 0.4× 185 0.3× 126 0.2× 333 0.6× 289 0.6× 57 1.6k
Eleni Gavriilaki Greece 28 269 0.4× 165 0.2× 84 0.1× 339 0.6× 1.0k 2.1× 189 2.8k
Pamir Atagündüz Türkiye 22 331 0.5× 120 0.2× 108 0.2× 574 1.1× 412 0.8× 64 1.7k
Helena Forsblad‐d’Elia Sweden 37 652 0.9× 107 0.2× 97 0.2× 2.3k 4.4× 1.0k 2.0× 121 3.5k
Joachim Misselwitz Germany 27 529 0.8× 358 0.5× 45 0.1× 99 0.2× 332 0.7× 51 2.4k
Erkan Demirkaya Türkiye 20 896 1.3× 249 0.4× 25 0.0× 285 0.5× 560 1.1× 114 1.9k

Countries citing papers authored by Serdal Uğurlu

Since Specialization
Citations

This map shows the geographic impact of Serdal Uğurlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdal Uğurlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdal Uğurlu more than expected).

Fields of papers citing papers by Serdal Uğurlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serdal Uğurlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdal Uğurlu. The network helps show where Serdal Uğurlu may publish in the future.

Co-authorship network of co-authors of Serdal Uğurlu

This figure shows the co-authorship network connecting the top 25 collaborators of Serdal Uğurlu. A scholar is included among the top collaborators of Serdal Uğurlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serdal Uğurlu. Serdal Uğurlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uğurlu, Serdal, et al.. (2026). Familial Mediterranean Fever: A Comprehensive Review of Pathogenesis, Genetics, and Epigenetic Regulation. Balkan Medical Journal. 43(1). 3–14.
2.
Uğurlu, Serdal, et al.. (2025). Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications. Internal and Emergency Medicine. 20(3). 797–803.
3.
Uğurlu, Serdal, et al.. (2024). Factors triggering familial mediterranean fever attacks, do they really exist?. Internal and Emergency Medicine. 19(4). 1007–1013. 5 indexed citations
4.
Kaya, Eda, Zeliha Tülek, Burç Çağrı Poyraz, et al.. (2024). Sexual dysfunction among female patients with rheumatic diseases. Rheumatology International. 44(10). 2099–2109. 1 indexed citations
5.
6.
Uğurlu, Serdal, et al.. (2024). Targeting complement dysregulation: eculizumab in scleroderma renal crisis management—a case-based review. Rheumatology International. 44(12). 3135–3140. 2 indexed citations
7.
Uğurlu, Serdal, et al.. (2024). Anakinra in the management of adult-onset still’s disease: a single-center experience. Internal and Emergency Medicine. 20(1). 131–138.
8.
Can, Günay, et al.. (2023). Cancer incidence in Familial Mediterranean Fever: A retrospective analysis. Seminars in Arthritis and Rheumatism. 63. 152284–152284.
9.
Hatemi, Gülen, Sinem Nihal Esatoğlu, Yeşim Özgüler, et al.. (2023). Infliximab for vascular involvement in Behçet's syndrome. Clinical Immunology. 253. 109682–109682. 9 indexed citations
10.
Seyahi, Emire, et al.. (2023). Behçet disease, familial Mediterranean fever and MEFV variations: More than just an association. Clinical Immunology. 251. 109630–109630. 8 indexed citations
11.
Uğurlu, Serdal, et al.. (2023). FMF presented by aseptic abscesses. 15(3). 167–170. 1 indexed citations
12.
Engіn, Burhan, et al.. (2023). Effectiveness of anti‐interleukin‐23 therapy in psoriatic arthritis: A pilot prospective real‐world study. International Journal of Rheumatic Diseases. 26(5). 878–884. 4 indexed citations
13.
Uğurlu, Serdal, et al.. (2023). A review of rheumatoid meningitis with case studies. Modern Rheumatology Case Reports. 7(2). 340–346. 2 indexed citations
14.
Bolayırlı, Murat, Günay Can, Gülen Hatemi, et al.. (2022). Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine. Journal of Medical Virology. 94(7). 3431–3437. 6 indexed citations
15.
Seyahi, Emire, et al.. (2021). Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center. TURKISH JOURNAL OF MEDICAL SCIENCES. 1 indexed citations
16.
Poyraz, Burç Çağrı, Necdet Süt, Serdal Uğurlu, et al.. (2021). Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatology International. 41(6). 1105–1114. 86 indexed citations
17.
Esatoğlu, Sinem Nihal, Emire Seyahi, Serdal Uğurlu, et al.. (2017). Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-up.. PubMed. 34(6 Suppl 102). 92–96. 12 indexed citations
18.
Youngstein, Taryn, Patrycja Hoffmann, Ahmet Gül, et al.. (2017). International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Lara D. Veeken. 56(12). 2102–2108. 88 indexed citations
19.
Özdoğan, Huri & Serdal Uğurlu. (2017). Canakinumab for the treatment of familial Mediterranean fever. Expert Review of Clinical Immunology. 13(5). 393–404. 36 indexed citations
20.
Köksal, Güniz M., et al.. (2007). Endolaparoscopic Approach in the Management of Gastroesophageal Reflux Disease: An Experimental Study in Pigs. Journal of Laparoendoscopic & Advanced Surgical Techniques. 17(5). 639–644. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026